Circulating tumor cells in breast cancer: a tool whose time has come of age (Q21245253)

12 October 2019

cytological procedure

1 reference

19 November 2020

1 reference

Massimo Cristofanilli

2

Massimo

Cristofanilli

Massimo Cristofanilli

1 reference

Dimensions Publication ID

Dimensions

19 August 2022

Ramona F Swaby

1

Ramona F

Swaby

1 reference

Dimensions Publication ID

Dimensions

1051091766

Creative Commons Attribution 2.0 Generic

19 August 2022

language of work or name

English

0 references

publication date

21 April 2011

6 references

13 March 2019

3 April 2019

17 June 2019

19 September 2019

12 October 2019

19 November 2020

6 references

13 March 2019

3 April 2019

17 June 2019

19 September 2019

12 October 2019

19 November 2020

9

0 references

issue

1

0 references

page(s)

43

0 references

copyright license

6 references

13 March 2019

3 April 2019

17 June 2019

19 September 2019

12 October 2019

on focus list of Wikimedia project

19 November 2020

copyright status

copyrighted

0 references

ScienceSource

0 references

exact match

https://scigraph.springernature.com/pub.10.1186/1741-7015-9-43

0 references

cites work

Tumor self-seeding by circulating cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3107794

Parenteral anticoagulation for prolonging survival in patients with cancer who have no other indication for anticoagulation

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3107794

Breast cancer metastasis: markers and models

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3107794

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3107794

Molecular mechanisms of metastasis in breast cancer--clinical applications

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3107794

Monitoring drug-induced gammaH2AX as a pharmacodynamic biomarker in individual circulating tumor cells

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3107794

Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19/mammaglobin RT-PCR in patients with metastatic breast cancer

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3107794

Circulating tumor cells: evolving evidence and future challenges

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3107794

Circulating tumour cells are associated with increased risk of venous thromboembolism in metastatic breast cancer patients

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3107794

Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3107794

Is there a role for positron emission tomography in breast cancer staging?

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3107794

uPAR and HER-2 gene status in individual breast cancer cells from blood and tissues

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3107794

Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3107794

A disaccharide precursor of sialyl Lewis X inhibits metastatic potential of tumor cells.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3107794

In vivo phage display and vascular heterogeneity: implications for targeted medicine

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3107794

Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3107794

Circulating tumor cells and bone metastases as detected by FDG-PET/CT in patients with metastatic breast cancer.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3107794

Role of 2-[18F]-fluorodeoxyglucose (FDG) positron emission tomography (PET) in the early assessment of response to chemotherapy in metastatic breast cancer patients

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3107794

Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system.

30 May 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-9-43

Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-9-43

Sequential positron emission tomography using [18F]fluorodeoxyglucose for monitoring response to chemotherapy in metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-9-43

Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-9-43

HER2 status predicts the presence of circulating tumor cells in patients with operable breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-9-43

Early prediction of response to chemotherapy in metastatic breast cancer using sequential 18F-FDG PET.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3107794

Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3107794

Warfarin for cancer prevention

29 November 2018

1 reference

12 December 2020

Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival

1 reference

12 December 2020

Factor XIII transglutaminase supports hematogenous tumor cell metastasis through a mechanism dependent on natural killer cell function

1 reference

12 December 2020

Circulating tumor cells in metastatic breast cancer: from prognostic stratification to modification of the staging system?

1 reference

12 December 2020